Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso

NCT04695197 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

143

Enrollment

OTHER

Sponsor class

Conditions

Covid-19
Malaria

Interventions

DRUG: Artemether-lumefantrine (AL)
DRUG: Pyronaridine-artesunate (PA)

Sponsor

Liverpool School of Tropical Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]